How Is immunitoAI Transforming Antibody Discovery With AI?

Indian Healthcare Makeover

GenAI is revolutionizing lab assistance, clinical diagnosis, health monitoring, and drug discovery, now aiding in medicine and antibody discovery against severe diseases.

High Costs and Long Timelines

Drug discovery often takes over a decade and billions of dollars. Making this technology cost-effective and more agile.

immunitoAI's Vision

Founded in 2020, immunitoAI uses AI to expedite and reduce the cost of antibody discovery, aiming to transform the biotech industry.

Market Potential

The biotech market is projected to reach $13.21 billion by 2028. immunitoAI seeks to cut drug discovery time from 4-5 years to 11-12 months.

Technological Innovation

immunitoAI's platform includes imDESIGN for creating new antibodies and imRANK for evaluating them, using advanced AI models and neural networks.

Challenges and Achievements

Despite skepticism, immunitoAI achieved 90-95% accuracy in generating viable antibody sequences, proving the potential of AI in biotech.

Future Plans

Collaborating with pharmaceutical companies, immunitoAI aims to reduce initial drug discovery time and cost, while preparing for future funding rounds.

How immunitoAI Is Changing The Rule Of Antibody Discovery With Its AI Stack